Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team
- PMID: 31173748
- PMCID: PMC8651298
- DOI: 10.1016/j.ajog.2019.05.035
Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team
Abstract
Objective: In a 2015 Maternal-Fetal Medicine Units Network study, only half of placenta accreta spectrum cases were suspected before delivery, and the outcomes in the anticipated cases were paradoxically poorer than in unanticipated placenta accreta spectrum cases. This was possibly because the antenatally suspected cases were of greater severity. We sought to compare the outcomes of expected vs unexpected placenta accreta spectrum in a single large US center with multidisciplinary management protocol.
Study design: This was a retrospective cohort study carried out between Jan. 1, 2011, and June 30, 2018, of all histology-proven placenta accreta spectrum deliveries in an academic referral center. Patients diagnosed at the time of delivery were cases (unexpected placenta accreta spectrum), and those who were antentally diagnosed were controls (expected placenta accreta spectrume). The primary and secondary outcomes were the estimated blood loss and the number of red blood cell units transfused, respectively. Variables are reported as median and interquartile range or number (percentage). Analyses were made using appropriate parametric and nonparametric tests.
Results: Fifty-four of the 243 patients (22.2%) were in the unexpected placenta accreta spectrum group. Patients in the expected placenta accreta spectrum group had a higher rate of previous cesarean delivery (170 of 189 [89.9%] vs 35 of 54 [64.8%]; P < .001) and placenta previa (135 [74.6%] vs 19 [37.3%]; P < .001). There was a higher proportion of increta/percreta in expected placenta accreta spectrum vs unexpected placenta accreta spectrum (125 [66.1%] vs 9 [16.7%], P < .001). Both primary outcomes were higher in the unexpected placenta accreta spectrum group (estimated blood loss, 2.4 L [1.4-3] vs 1.7 L [1.2-3], P = .04; red blood cell units, 4 [1-6] vs 2 [0-5], P = .03).
Conclusion: Our data contradict the Maternal-Fetal Medicine Units results and instead show better outcomes in the expected placenta accreta spectrum group, despite a high proportion of women with more severe placental invasion. We attribute this to our multidisciplinary approach and ongoing process improvement in the management of expected cases. The presence of an experienced team appears to be a more important determinant of maternal morbidity in placenta accreta spectrum than the depth of placental invasion.
Keywords: abnormally invasive placenta; antenatal diagnosis; center of excellence; depth of invasion; morbidly adherent placenta; multidisciplinary management; placenta accreta; placenta accreta spectrum disorder.
Copyright © 2019 Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors report no conflicts of interest.
Similar articles
-
Placenta percreta is associated with more frequent severe maternal morbidity than placenta accreta.Am J Obstet Gynecol. 2018 Aug;219(2):193.e1-193.e9. doi: 10.1016/j.ajog.2018.04.049. Epub 2018 May 5. Am J Obstet Gynecol. 2018. PMID: 29733839
-
Placenta Accreta Spectrum Treatment With Intraoperative Multivessel Embolization: the PASTIME protocol.Am J Obstet Gynecol. 2021 Oct;225(4):442.e1-442.e10. doi: 10.1016/j.ajog.2021.07.001. Epub 2021 Jul 7. Am J Obstet Gynecol. 2021. PMID: 34245679
-
Outcomes following a clinical algorithm allowing for delayed hysterectomy in the management of severe placenta accreta spectrum.Am J Obstet Gynecol. 2020 Feb;222(2):179.e1-179.e9. doi: 10.1016/j.ajog.2019.08.035. Epub 2019 Aug 27. Am J Obstet Gynecol. 2020. PMID: 31469990
-
Comparison of maternal outcomes and clinical characteristics of prenatally vs nonprenatally diagnosed placenta accreta spectrum: a systematic review and meta-analysis.Am J Obstet Gynecol MFM. 2023 Dec;5(12):101197. doi: 10.1016/j.ajogmf.2023.101197. Epub 2023 Oct 20. Am J Obstet Gynecol MFM. 2023. PMID: 37865220 Review.
-
Placenta accreta spectrum: accreta, increta, and percreta.Obstet Gynecol Clin North Am. 2015 Jun;42(2):381-402. doi: 10.1016/j.ogc.2015.01.014. Obstet Gynecol Clin North Am. 2015. PMID: 26002174 Review.
Cited by
-
Obstetric and haematological management and outcomes of women with placenta accreta spectrum by planned or urgent delivery: Secondary data analysis of a public referral hospital in Lebanon.PLoS One. 2024 May 8;19(5):e0302366. doi: 10.1371/journal.pone.0302366. eCollection 2024. PLoS One. 2024. PMID: 38718031 Free PMC article.
-
Placenta accreta outcomes and risk factors in a referral hospital in north of Iran: A case control study.Health Sci Rep. 2024 Apr 10;7(4):e2006. doi: 10.1002/hsr2.2006. eCollection 2024 Apr. Health Sci Rep. 2024. PMID: 38605724 Free PMC article.
-
Assisted reproductive technology-associated risk factors for placenta accreta spectrum after vaginal delivery.Sci Rep. 2024 Mar 29;14(1):7454. doi: 10.1038/s41598-024-57988-x. Sci Rep. 2024. PMID: 38548810 Free PMC article.
-
Risk factors for placenta accreta spectrum disorders in women with any prior cesarean and a placenta previa or low lying: a prospective population-based study.Sci Rep. 2024 Mar 19;14(1):6564. doi: 10.1038/s41598-024-56964-9. Sci Rep. 2024. PMID: 38503816 Free PMC article.
-
Serum exosomal microRNA pathway activation in placenta accreta spectrum: pathophysiology and detection.AJOG Glob Rep. 2024 Feb 10;4(1):100319. doi: 10.1016/j.xagr.2024.100319. eCollection 2024 Feb. AJOG Glob Rep. 2024. PMID: 38440154 Free PMC article.
References
-
- Belfort MA. Placenta accreta. Am J Obstet Gynecol 2010;203:430–9. - PubMed
-
- Solheim KN, Esakoff TF, Little SE, Cheng YW, Sparks TN, Caughey AB. The effect of cesarean delivery rates on the future incidence of placenta previa, placenta accreta, and maternal mortality. J Matern Fetal Neonat Med 2011;24:1341–6. - PubMed
-
- Thurn L, Lindqvist PG, Jakobsson M, Colmorn LB, Klungsoyr K, Bjarnadottir RI, et al. Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the Nordic countries. BJOG 2016;123: 1348–55. - PubMed
-
- Bowman ZS, Eller AG, Kennedy AM, et al. Accuracy of ultrasound for the prediction of placenta accreta. Am J Obstet Gynecol 2014;211:177.e1–7. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical